New shot aims to tame painful arthritis flares
NCT ID NCT06590090
Summary
This study is testing whether a new injectable drug called Natrunix, when added to standard methotrexate treatment, can better control the symptoms of moderate to severe rheumatoid arthritis. About 108 adults whose arthritis isn't well-controlled on methotrexate alone will receive either the new injection or a placebo for 14 weeks, followed by an option for everyone to try the new drug. The main goal is to see if it reduces joint pain and swelling more effectively.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.